Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.
about
Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancerHepatocyte growth factor-like protein is a positive regulator of early mammary gland ductal morphogenesisRon receptor signaling is protective against DSS-induced colitis in mice.Loss of Ron receptor signaling leads to reduced obesity, diabetic phenotypes and hepatic steatosis in response to high-fat diet in miceSOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor CellsHGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses.A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancerInflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters.Recepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer.Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.Epigenetic basis of cancer health disparities: Looking beyond genetic differences.Progress in tumor-associated macrophage (TAM)-targeted therapeutics.Autoinhibition of the Ron receptor tyrosine kinase by the juxtamembrane domain.HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling.Hepatocyte growth factor-like protein is required for prostate tumor growth in the TRAMP mouse model.Inhibition of ron kinase blocks conversion of micrometastases to overt metastases by boosting antitumor immunity.RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers.Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowthTumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation
P2860
Q26858922-433AC02E-52D6-43FA-9ED8-0C96A3C4D0E9Q28593437-40AF52F4-A413-4D1F-8E12-5E2DE4E768BDQ33764576-24EF9C99-8F93-4FB7-99D5-B1CC9C62DAE1Q35273848-D7DA4515-A22F-469D-980F-20354CB852CEQ36061481-BE8DABC6-ADCA-47F9-B643-3F3AFBCBF2B7Q36232073-A4B52475-D05F-4F67-B464-577E9493B26AQ36814075-FF5CD34D-E88C-4BD3-9BE2-86E579EA9CE5Q37046523-0541733C-6A9A-4F28-AE41-043B9D581D0BQ37618229-FC4BF6C8-BCCA-4E44-A9FA-A8187E2BD751Q38543678-314E6303-EEAB-41DE-91C3-4DB8283526BFQ38922319-276D9451-5BDA-497F-B9C7-370392CBD894Q39096966-5EDDE6A0-9DBC-4C74-89B8-93425F95109CQ39267549-209383B4-2C42-41B4-9945-FC5ACA1407E4Q39628474-DC87C4DE-C1DC-4331-AEC1-C41BC94292A8Q41708922-2955CE32-F218-4386-A6BB-562649992B85Q41814227-56938950-2088-406D-9EF9-2642D416055EQ42723155-CE806031-1D9E-4472-BEF6-1CF73E01DF2EQ53591553-B85F78D8-9525-4D84-82B7-96B686B9E692Q56891079-6B3EC576-9C19-4BF4-8627-BC6C2EBC9F7EQ58777826-69867160-792D-4175-B531-04FEBF29925E
P2860
Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.
@ast
Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.
@en
type
label
Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.
@ast
Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.
@en
prefLabel
Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.
@ast
Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.
@en
P2093
P2860
P1433
P1476
Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth
@en
P2093
Devikala Gurusamy
Fred D Finkleman
Jerilyn K Gray
Peterson Pathrose
Rishikesh M Kulkarni
P2860
P304
P356
10.1158/0008-5472.CAN-12-2474
P407
P577
2013-01-17T00:00:00Z